Overview

• India’s emerging pharmaceutical Company, that manufactures and markets world-class generics, branded generic pharmaceuticals.
• The structuring of our product portfolio into primary, secondary and tertiary brands will help to create power. New products have a sharper focus with a specialized management team looking into opportunities and launches. GPL will grow market share through a combination of new products, innovative selling and brand management.
• Our sales, marketing and distribution network is segregated into discrete divisions with a disease focus to improve customer coverage. The size of the field forces and the strong training and motivation inputs that will be continually provided will enable the company leverage scale and penetration significantly.
• A modern state of art facility at Kolkata,West Bengal manufacturing Tablets,Capsules,Oral Liquid, Topical ointment and SVP in Non Beta Lactum segment.
• Another modern state of art facility adhering to USFDA which high productivity is coming up at Martam in East district of Sikkim.
• In licensing and Alliances remain an important component of our strategy for the near to medium term. Given its importance in our strategy, our company has a dedicated management team to source new product and alliances opportunities, both domestically and globally.